Article info
PDFCurrent controversy
Application of a medicolegal approach in clinical stalemates
- Correspondence to Michael Tang, Yale School of Public Health, Yale University, 60 College Street, New Haven, CT 06520-8034, USA; michael.tang{at}yale.edu
Citation
Application of a medicolegal approach in clinical stalemates
Publication history
- Received March 11, 2012
- Accepted August 1, 2012
- First published August 24, 2012.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Management of acute ischemic stroke
- Influence of intravenous alteplase on endovascular treatment decision-making in acute ischemic stroke due to primary medium-vessel occlusion: a case-based survey study
- Endovascular therapy of acute ischemic stroke: report of the Standards of Practice Committee of the Society of NeuroInterventional Surgery
- CODE FAST: a quality improvement initiative to reduce door-to-needle times
- Review of current and emerging therapies in acute ischemic stroke
- Question 2: Should thrombolytic agents be used in children presenting with acute ischaemic stroke?
- Initial hospital management of patients with emergent large vessel occlusion (ELVO): report of the standards and guidelines committee of the Society of NeuroInterventional Surgery
- Intervention in acute cerebral ischaemic stroke: a review of the role of pharmacological therapies and intra-arterial mechanical thrombectomy devices
- Equipoise, standard of care and consent: responding to the authorisation of new COVID-19 treatments in randomised controlled trials
- AHA/ASA 2018 AIS guidelines: impact and opportunity for endovascular stroke care